Masthead-Image-Right-min

The End of an Era: FDA is Rescinding Long-Contested LDT Rule for Labs

Withdrawal of LDT Rule Provides Regulatory Clarity and Reimbursement Guidance for Laboratories

Continue Reading...

UnitedHealth Group's Turmoil: The Impact on Labs and Pathology Groups

Rising costs, regulatory scrutiny, and shifting payer dynamics could reshape lab and pathology practice operations and reimbursements.

Continue Reading...

Healthcare's New Law: Preparing for the “One Big Beautiful Bill” Act

The new law brings transformative changes to Medicare, Medicaid, and patient cost-sharing, requiring providers to strategically adapt revenue cycle operations.

Continue Reading...

What's Next for LDTs? A Look Beyond the Ruling

Get the key takeaways from our expert-led webinar on the LDT final rule ruling—and why labs must stay vigilant as the story unfolds.

Continue Reading...

The Road Ahead: 7 RCM Trends to Watch in 2025

Discover the top trends in healthcare revenue cycle management for 2025, including AI, RPA, data analytics, blockchain, and patient engagement strategies.

Continue Reading...